ReviewHuman mutation2012

Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Silvie Foldynova-Trantirkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.